N-Linked Glycosylation is Essential for IGF-1 Signaling in CHO Cells

Insulin-like Growth Factor 1 (IGF-1) is a crucial hormone involved in cell growth, proliferation, and survival, playing a significant role in development and various diseases like cancer and metabolic disorders. Its signaling pathway is complex, involving receptor binding and downstream activation of pathways like PI3K/Akt. N-linked glycosylation, the attachment of oligosaccharides to asparagine residues of proteins, is a common post-translational modification critical for protein folding, stability, and function. While the importance of IGF-1 signaling and glycosylation are well-established individually, the specific role of N-linked glycosylation in modulating IGF-1 receptor function and downstream signaling in Chinese Hamster Ovary (CHO) cells remained underexplored.

The study revealed that N-linked glycosylation is indeed critical for robust IGF-1 signaling in CHO cells. Treatment with tunicamycin significantly reduced IGF-1R phosphorylation by over 70% compared to untreated controls (p<0.001). Furthermore, downstream signaling, specifically the phosphorylation of Akt, was dramatically impaired, showing a 65% decrease in p-Akt levels (p<0.001). These glycosylation-deficient cells also exhibited altered expression of genes involved in cell cycle progression, with CDK2 mRNA levels reduced by 40% (p<0.01). The overall cellular response to IGF-1, including survival and growth, was severely compromised in the absence of proper N-linked glycosylation. Genetic deletion of ST6GAL1 resulted in a profound 85% reduction in IGF-1-induced cell proliferation and a 50% decrease in IGF-1R surface expression, highlighting the specific role of sialylation in receptor availability and function.